September 2, 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives (PR Newswire via Yahoo! Finance)
Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the appointment of Patrick O’Connor, PhD, Vice President, Research, Michael J.
Original post by Epinions Recent Content for Golf
Leave a comment
You must be logged in to post a comment.